Khaliullin, F. A.,
Klen, E. E.,
Nikitina, I. L.,
Pavlov, V. N.,
Rozit, G. A.,
Gaisina, G. G.,
Samorodov, A. V. (2023) IXa is a
low-toxic substance (class 4 toxicity) with a high bioavailability predicted according
Gareev, Ilgiz,
Encarnacion Ramirez, Manuel de Jesus,
Nurmukhametov, Renat,
Ivliev, Denis,
Shumadalova, Alina,
Ilyasova, Tatiana,
Beilerli, Aferin,
Wang, Chunlei (2023) for most glioma patients remains dishearteningly
low. Hence, there is an urgent necessity to discover novel
Пути развития иммунотерапии колоректального рака low efficacy and the development of a number of side effects with damage to the liver, lung
Bovell-Ammon, B.J.,
Kimmel, S.D.,
Cheng, D.M.,
Truong, V.,
Michals, A.,
Vetrova, M.,
Hook, K.,
Idrisov, B.,
Blokhina, E.,
Krupitsky, E.,
Samet, J.H.,
Lunze, K. (2023) : Prior incarceration was common, and rates of prior ART initiation were
low even though most participants